We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+12.64%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$283M
AUM Growth
+$80.6M
(+40%)
Cap. Flow
+$74.6M
Cap. Flow
% of AUM
26.38%
Top 10 Holdings %
Top 10 Hldgs %
75.07%
Holding
61
New
12
Increased
13
Reduced
5
Closed
15
Top Buys
| 1 |
GE HealthCare
GEHC
|
+$32.2M |
| 2 |
Labcorp
LH
|
+$32M |
| 3 |
GSK
GSK
|
+$17.2M |
| 4 |
Globus Medical
GMED
|
+$8.27M |
| 5 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$6.75M |
Top Sells
| 1 |
Centene
CNC
|
+$27.4M |
| 2 |
Cencora
COR
|
+$20.5M |
| 3 |
Medtronic
MDT
|
+$6.77M |
| 4 |
Avantor
AVTR
|
+$5.99M |
| 5 |
Relay Therapeutics
RLAY
|
+$3.79M |
Sector Composition
| 1 | Healthcare | 99.16% |
| 2 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
GE HealthCare
GEHC
$28.9B
| $48.7M | 17.23% |
599,808
+402,921
| +205% | +$32.2M |
|
|
2
Labcorp
LH
$22.6B
| $34.2M | 12.11% |
+165,179
| New | +$32M |
|
3
Cigna
CI
$79.8B
| $31.6M | 11.18% |
112,674
+25,499
| +29% | +$6.64M |
|
|
BCYC
4
Bicycle Therapeutics
BCYC
$290M
| $24.7M | 8.74% |
968,671
+1,324
| +0.1% | +$30.8K |
|
5
United Therapeutics
UTHR
$22.6B
| $17.6M | 6.24% |
79,926
+4,923
| +7% | +$1.09M |
|
|
6
GSK
GSK
$103B
| $17.1M | 6.04% |
+479,532
| New | +$17.2M |
|
|
7
Globus Medical
GMED
$10.6B
| $12.7M | 4.48% |
212,593
+145,093
| +215% | +$8.27M |
|
8
ADC Therapeutics
ADCT
$158M
| $8.64M | 3.06% |
4,020,705
+1,860,073
| +86% | +$4.18M |
|
9
Viking Therapeutics
VKTX
$4.39B
| $8.55M | 3.02% |
527,657
+277,657
| +111% | +$5.82M |
|
10
Organon & Co
OGN
$3.54B
| $8.43M | 2.98% |
404,938
-66,615
| -14% | -$1.45M |
|
|
AXNX
11
DELISTED
Axonics, Inc. Common Stock
AXNX
| $8.28M | 2.93% |
164,017
+93,176
| +132% | +$4.96M |
|
|
PDCO
12
DELISTED
Patterson Companies, Inc.
PDCO
| $8.15M | 2.88% |
+245,000
| New | +$6.75M |
|
13
Humana
HUM
$49.5B
| $5.81M | 2.06% |
+13,000
| New | +$6.54M |
|
|
CNTA
14
DELISTED
Centessa Pharmaceuticals
CNTA
| $5.43M | 1.92% |
877,193
+529,324
| +152% | +$2.51M |
|
|
IMGN
15
DELISTED
Immunogen Inc
IMGN
| $4.64M | 1.64% |
+245,921
| New | +$2.9M |
|
16
Nektar Therapeutics
NKTR
$2.29B
| $4.02M | 1.42% |
+466,359
| New | +$4.97M |
|
17
ARS Pharmaceuticals
SPRY
$716M
| $3.64M | 1.29% |
+542,576
| New | +$3.62M |
|
|
RVNC
18
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.58M | 1.27% |
+141,500
| New | +$4.41M |
|
|
MACK
19
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $3.58M | 1.26% |
290,749
+17,906
| +7% | +$224K |
|
20
X4 Pharmaceuticals
XFOR
$362M
| $3.39M | 1.2% |
+58,300
| New | +$3M |
|
21
Savara
SVRA
$1.18B
| $3.23M | 1.14% |
1,010,701
+62,244
| +7% | +$146K |
|
22
Arcutis Biotherapeutics
ARQT
$3.48B
| $2.79M | 0.99% |
+293,047
| New | +$3.25M |
|
|
VRAY
23
DELISTED
ViewRay, Inc.
VRAY
| $2.27M | 0.8% |
+6,431,349
| New | +$6.66M |
|
24
IDEAYA Biosciences
IDYA
$3.54B
| $1.75M | 0.62% |
74,594
+4,594
| +7% | +$94.5K |
|
|
NYXH
25
Nyxoah
NYXH
$156M
| $1.6M | 0.57% |
200,076
+11,201
| +6% | +$91.2K |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA